BioCentury
ARTICLE | Clinical News

NicOx starts Phase I/II study

March 15, 2000 8:00 AM UTC

NicOx (NM:Nicox) started a French Phase I/II trial in 19 volunteers of its topical formulation of HCT-1026, a nitro-flurbiprofen derivative, to treat dermatological disorders. The trial will assess to...